Cardiac glycosides potently inhibit C-reactive protein synthesis in human hepatocytes

The inhibitory activity of cardiac glycosides on CRP expression may have important implications for the treatment of cardiovascular disease. Cardiac glycosides may be used for CRP synthesis inhibition in the future.